Biosynthetic Technologies Obtains $100 Million Loan Pledge from the USDA

February 3, 2016 9:30 AM

Moves a step closer to a commercial-scale renewable chemicals manufacturing plant IRVINE, CA / ACCESSWIRE / February 3, 2016 / Biosynthetic(TM) Technologies, developer of a breakthrough class of renewable chemicals, has received approval from the U.S. Department of Agriculture on its Phase One application under the USDA's Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program (the "9003 Program"). USDA Rural...

Read more

mPhase Presenting 'Smart Batteries to Smart Drug Delivery Systems' at NIBA Conference

February 3, 2016 9:20 AM

CLIFTON, NJ / ACCESSWIRE / February 3, 2016 / mPhase Technologies, Inc. (OTC: XDSL), announced today that the company will be presenting at The National Investment Banking Association (NIBA) February 10-11, 2016. This year's conference is being held in Hollywood, FL. mPhase Technologies Inc.'s CEO and President, Mr. Ronald Durando, will speak about the company's award winning nanotechnology and its current Notice of Allowance for a patent...

Read more

mPhase Technologies Says Its New Drug Delivery System Could Prove Very Useful for Diabetics

January 26, 2016 9:20 AM

CLIFTON, NJ / ACCESSWIRE / January 26, 2016 / mPhase Technologies, Inc. (OTC: XDSL) (http://www.mPhaseTech.com) said today that its new, patented Drug Delivery System could prove especially useful and efficacious for patients taking insulin for diabetes, according to Company research. Ronald A. Durando, the Company's Chairman, President and CEO, said mPhase Technologies' new invention automatically dispenses a pre-set dosage of a drug such as...

Read more

mPower Technologies Offers Special Promo Pricing on the mPower FastCharge

January 20, 2016 9:33 AM

CLIFTON, NJ / ACCESSWIRE / January 20, 2016 / mPower Technologies Inc. (http://mpowertech.com/), the consumer products subsidiary of mPhase Technologies, Inc. (XDSL), announced today that the company is promoting a special offer on the newest product in the line. The mPower FastCharge is available on the website and the orange units have a special promo 'Buy One, Get One Half Off' with free shipping within the continental US. It's a great gift...

Read more

Immune Therapeutics to Present at the SeeThruEquity 1st Annual Microcap Healthcare Investor Conference

January 11, 2016 1:38 PM

SAN FRANCISCO, CA / ACCESSWIRE / January 11, 2016 / Immune Therapeutics, Inc. (OTCQB: IMUN) a biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system using its patented immunotherapy, will present at the SeeThruEquity First Annual Microcap Healthcare Investor Conference on Monday, January 11th, 2016 at The Fairmont in San Francisco, California.Immune...

Read more

mPhase Technologies Receives Notice of Allowance of a Patent for New Drug Delivery System

January 5, 2016 9:00 AM

CLIFTON, NJ / ACCESSWIRE / January 5, 2016 / mPhase Technologies, Inc. (OTC: XDSL) (http://www.mPhaseTech.com) is pleased to announced that the U.S. Patent and Trademark Office has awarded a Notice of Allowance of a Patent covering a "new and useful" Drug Delivery System said Ronald A. Durando, the Company's Chairman, President and CEO. The invention allows a drug delivery system to automatically dispense a pre-set dosage of a drug or...

Read more

Algae Dynamics Corp Announces OTCQB Application

January 4, 2016 9:00 AM

TORONTO, CANADA / ACCESSWIRE / January 4, 2016 / ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation system for the growth of algae strains for use in the food and health supplement industry, announced today that it has applied to list and trade the company's common shares on the OTCQB Marketplace. The OTCQB is considered by the SEC as an...

Read more

Vitro Biopharma Advances Stem Cell Activation Therapy for Concussion

December 29, 2015 9:30 AM

GOLDEN, CO / ACCESSWIRE / December 29, 2015 / Vitro Diagnostics, Inc. (OTC: VODG), dba Vitro Biopharma, announced new developments of its stem cell activation therapy for concussion. Dr. Omula's research tying repetitive concussion to chronic traumatic encephalopathy is chronicled in the recently released movie, "Concussion." Vitro Biopharma is a leader in the field of stem cell activation therapy now focused on treatment of concussion/TBI. ...

Read more

Rosetta Genomics to Present at the LD Micro Main Event

November 24, 2015 8:30 AM

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / November 24, 2015 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today announced that it will be presenting at the 8th annual LD Micro Main Event on Wednesday, December 2nd at 8:30 a.m. PST/11:30 a.m. EST. Kenneth A. Berlin, Rosetta's President and Chief Executive Officer, will be giving the presentation and meeting...

Read more

CEO Letter to Shareholders: 2015 Results Expand Therapy Options for Concussion

November 4, 2015 1:12 PM

GOLDEN, CO / ACCESSWIRE / November 4, 2015 / Dear Shareholders: Concussion and traumatic brain injury (TBI) are significant health risks that lack modern therapeutic approaches beyond physical therapy and rehabilitation. The TBI incidence in the US is 1.5 to 1.7 million new cases per year and is estimated to cost $75 billion per year in the US only. Concussion is a growing issue within professional athletes including the NFL where significant...

Read more

Accurexa Enters into Collaboration with The Hebrew University of Jerusalem

November 2, 2015 8:00 AM

NEWWARK, DE / ACCESSWIRE / November 2, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that it entered into an agreement with the Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. ("Yissum") to develop and supply a polymeric formulation of a combination of carmustine and...

Read more

Hema Diagnostic Systems, L.L.C. Announces the Final Validation Process for a New Rapid Anthrax Ab Test

October 15, 2015 2:54 PM

Hema Diagnostic Systems (HDS) Announces the Final Validation Process of a New Anthrax Toxin Rapid Test for the Detection and Differentiation Between the Anthrax Protective Antigen (PA) and the Lethal Factor (LF) Using Whole Blood or Serum MIRAMAR, FL / ACCESSWIRE / October 15, 2015 / Hema Diagnostic Systems, LLC, a US based medical device company, announced today in Miramar, Florida, the final evaluation phase of its' new rapid, whole...

Read more

Plandai Biotechnology, Inc. Announces Distribution Agreement with Coyne Healthcare for Phytofare(R)/Pheriod Finished Product(R)

October 12, 2015 9:54 AM

Shipments of Ph(2)(TM) Expected to Commence November 2015 LONDON, UK / ACCESSWIRE / October 12, 2015 / Plandaí Biotechnology, Inc. ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare(R) catechin complex, today announced that it has executed a distribution agreement covering 14 SADIC countries with Coyne Healthcare, a South African-based distributor of nutraceuticals and food supplements...

Read more

Algae Dynamics Corp Provides Corporate Update

October 1, 2015 10:29 AM

TORONTO, ON / ACCESSWIRE / October 1, 2015 / ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), is a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation system for the growth of algae strains for use in the food and health supplement industry, is issuing this press release to provide a corporate update. The following are some of the key milestones that position the Company for future development: -...

Read more

Accurexa to Present at 2015 Stem Cell Meeting on the Mesa

September 28, 2015 8:00 AM

NEWARK, DE / ACCESSWIRE / September 28, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that George Yu, MD, President & CEO, will present at the annual Partnering Forum, part of the Stem Cell Meeting on the Mesa to be held October 7-9 in La Jolla, California. This conference is the sector's premiere...

Read more

Avagenesis Corp. Receives Notice of Patent Allowance in Canada for Cell Isolation System

September 25, 2015 2:00 PM

CALGARY, AB / ACCESSWIRE / September 25, 2015 / Avagenesis Corp. ("Avagenesis" or the "Company") (TSX Venture: VVA), is pleased to announce that its licensed technology has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent application on adipose cell isolation technology. The Company anticipates the patent to be issued within 60 days. Once that occurs, patents will have been issued on the Company's...

Read more

Vitro Biopharma Launches New Bioanalytical Services and Novel Stem Cell-Derived Renal & Neural Cells

September 22, 2015 10:18 AM

GOLDEN, CO / ACCESSWIRE / September 22, 2015 / Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced expansion of its product/service offerings to include biomarker profiling services and stem cell derived neuronal and renal cells. Vitro Biopharma's new services include simultaneous determination of several molecules through multi-plexed assays. The cells of our bodies communicate with each other through the secretion of numerous...

Read more

Earth Science Tech, Inc. Releases New High Grade Hemp CBD Oil "Peppermint Tinctures and Vape E-Liquids" on its eCommerce Store

September 17, 2015 1:00 PM

BOCA RATON, FL / ACCESSWIRE / September 17, 2015 / Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology publicly traded company focused on nutraceuticals, bioceuticals and dietary supplements, releases its new scientifically formulated all-natural "High Grade Hemp CBD (Cannabidiol) Oil" Peppermint Tinctures and Vape E-Liquids (E-Juices) for sale on its newly upgraded online eCommcerce store domain name...

Read more

Algae Dynamics Corp Finalizes Financing Terms with Ry Capital Group, LLC

September 14, 2015 4:05 PM

TORONTO, ON / ACCESSWIRE / September 14, 2015 / ALGAE DYNAMICS CORP (PINKSHEETS: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation system for the growth of algae strains for use in the food and health supplement markets, today announced it has completed a financing and established a facility expected to lead to additional funding within the next 60 days. The completed...

Read more

Earth Science Tech Announces Its Newly Formed Subsidiary "Earth Science Tech Bioceuticals" and Elects Joseph Pavlik as President

September 4, 2015 11:10 AM

BOCA RATON, FL / ACCESSWIRE / September 4, 2015 / Earth Science Tech, Inc., a unique biotechnology public company focused on nutraceuticals, bioceuticals and dietary supplements, announced today its creation of a new wholly owned subsidiary Earth Science Tech Bioceuticals, Inc. and concurrently elects Mr. Joseph Pavlik as President. Earth Science Tech Bioceuticals will be developing, bringing to market, and merchandising a number of breakthrough...

Read more